Scleroderma and silicone gel breast prostheses--the Sydney study revisited

Area of Science:

• Rheumatology
• Immunology
• Plastic Surgery

Background:

• Silicone augmentation mammoplasty has been questioned as a cause of environmentally-induced scleroderma.
• Previous studies reported no association, but lacked detailed prosthesis information and untraceable case data.
• This study aimed to validate augmentation mammoplasty status and re-evaluate the silicone gel prostheses-scleroderma link.

Purpose of the Study:

• To validate self-reported augmentation mammoplasty status in scleroderma patients and controls.
• To re-analyze exposure rates to silicone gel breast prostheses.
• To evaluate a potential causal link between silicone gel breast prostheses and scleroderma.

Main Methods:

• Population-based case-control study involving scleroderma patients and general practice controls in Sydney (1974-1988).
• Validation of augmentation mammoplasty status through medical practitioners and records.
• Surgical and prosthesis details obtained from plastic surgeons; scleroderma onset validated from medical records.

Main Results:

• Self-reported augmentation mammoplasty status was highly reliable (kappa=1 for cases, kappa=0.86 for controls).
• No association was found between silicone gel augmentation mammoplasty and scleroderma (unadjusted OR 1.33, adjusted OR 1.00).
• Validation of augmentation mammoplasty status was successful in over 87% of controls and 95% of cases.

Conclusions:

• This study validates the reliability of self-reported augmentation mammoplasty status.
• Findings do not support the hypothesis that silicone gel augmentation mammoplasty induces scleroderma.
• The research provides robust evidence against a causal link between silicone gel breast implants and scleroderma.